newsfilter
← Latest News
PR Newswire·

Nektar Therapeutics Reports First Quarter 2026 Financial Results

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2026. Cash and investments in marketable...